Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Acorda Therapeutics
Acorda Therapeutics
Biogen Idec's Critical Nerve Repair Drug is Poised for Big News -- Soon
TheStreet.com
Thu, 01/8/15 - 08:05 am
Biogen Idec
nerve repair
BIIB033
anti-LINGO-1
GSK
Vertex Pharmaceuticals
Acorda Therapeutics
3 Companies Growing Faster Than MannKind Corporation
Motley Fool
Wed, 12/17/14 - 08:13 am
MannKind
Alexion
Akorn
Acorda Therapeutics
Acorda posts 3Q revenue of $106 million, result beats expectations
Yahoo/AP
Thu, 10/30/14 - 12:15 pm
Acorda Therapeutics
earnings
Acorda Down on Plumiaz CRL
Yahoo/Zacks.com
Mon, 05/5/14 - 05:05 pm
Acorda Therapeutics
Plumiaz
epilepsy
Acorda Therapeutics says FDA rejects epilepsy drug
Yahoo/Reuters
Fri, 05/2/14 - 08:35 am
FDA
epilepsy
Acorda Therapeutics
Plumiaz
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
earnings
United Therapeutics
Celgene
Regeneron
Biogen Idec
Acorda Therapeutics
Amgen
Gilead Sciences
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
M&A
biotech
generics
Merck
Bristol-Myers Squibb
General Electric
Gilead Sciences
Thermo Fisher
Forest Labs
FDA
Acorda Therapeutics
Pfizer
JNJ
Roche
Pharmacyclics
Acorda Down on Q3 Earnings
Yahoo/Zacks
Mon, 11/4/13 - 09:59 am
earnings
Acorda Therapeutics
Acorda: A Biotech Company To Consider
Seeking Alpha
Sat, 04/13/13 - 11:44 am
Acorda Therapeutics
Acorda Therapeutics Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Wed, 02/13/13 - 11:02 am
Acorda Therapeutics
earnings
Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Regeneron
Biogen Idec
Acorda Therapeutics
Sanofi
Celgene
Alexion
Biomarin
NPS Pharmaceuticals
Cerner
EXACT Sciences
Pfizer
Bristol-Myers Squibb
Eli Lilly
Potentially game changing data awaits Acorda in 2013
Reuters
Fri, 12/21/12 - 10:42 am
Acorda Therapeutics
AMPYRA
stroke
Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool
Tue, 09/4/12 - 11:08 am
Neurocrine Biosciences
Acorda Therapeutics
Amarin
Nektar
Acorda Therapeutics posts 2nd-quarter profit as sales and royalties from MS drug rise
Yahoo/AP
Tue, 07/31/12 - 01:26 pm
earnings
Acorda Therapeutics
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Seeking Alpha
Mon, 06/25/12 - 11:22 am
Teva Pharmaceuticals
patents
Mylan
Momenta
Natco
Acorda Therapeutics
Copaxone
MS
multiple sclerosis
6 High-Growth Biotech Stocks Analysts Rate As Buys
Seeking Alpha
Fri, 05/18/12 - 05:18 pm
Bacterin
Biomarin
Athersys
Affymax
Acorda Therapeutics
Alexion
Acorda Therapeutics To FDA: What Deadlines?
Pharmalot
Thu, 05/17/12 - 10:23 am
FDA
Acorda Therapeutics
adverse events
AMPYRA
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
BIO CEO Conference
Pfizer
Indenix
Keryx
Delcath
Oncothyreon
Acorda Therapeutics
Human Genome Sciences
Gilead
20 Biotech Stocks That Hedge Funds Are Selling
Seeking Alpha
Sun, 12/11/11 - 02:40 pm
Nabi
Pacific Biosciences
Dendreon
Momenta
Enzon
Acorda Therapeutics
ShangPharma
Charles River Laboratories
Sangamo BioSciences
BioSpecifics Technologies
Jazz Pharmaceuticals
Amgen
Sinovac Biotech
ViroPharma
Vanda
Insmed
Transcept
Cadence Pharmaceuticals
PDL Biopharma
Chelsea Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »